Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets

September 14, 2010

Wellesley, Mass. – According to a new technical market research report, THERAPEUTICS AND BIOMATERIALS FOR MUSCULOSKELETAL DISEASE: GLOBAL MARKETS (HLC086A) from BCC Research (www.bccresearch.com), the value of the market for therapeutics and biomaterials for musculoskeletal disease was $44.8 billion in 2009, but is expected to increase to $57.8 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 5.2%.

The largest segment of the market, osteoarthritis therapeutics, is projected to increase at a CAGR of 5.6% to $19.1 billion in 2014, after being valued at $14.6 billion in 2009.

The rheumatoid arthritis segment was valued at $9.5 billion in 2009, and is expected to increase at a CAGR of 5.6% to reach nearly $12.5 billion in 2014.

The osteoporosis segment is projected to reach nearly $10.6 billion in value in 2014, rising at a CAGR of 2.3% from nearly $9.5 billion in 2009.

Other segments of the market worth from a high of $3.4 billion to a low of $1.4 billion in 2009 are  therapeutics for psoriatic arthritis, bone substitutes, lupus, synthetic bone grafts, and gout.

Musculoskeletal disease places a significant burden on the healthcare system and affects a large segment of the population. The musculoskeletal area overlaps in large part with autoimmune disease, as the cause of diseases like rheumatoid arthritis and lupus begins with an autoimmune reaction and leads to bone and joint damage.

Clinical success has proven elusive, as there are now numerous companies developing novel treatments. This report reviews the programs in development and quantifies the market opportunities in musculoskeletal diseases. This study aims to quantify the direction in which this market is heading and the areas in which opportunities may lie.

The intended audience for this report is the pharmaceutical and biotechnology diagnostics industries, as well as the medical industry that treats patients in these areas.

Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets( HLC086A )
Publish Date: Jul 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.